We Have Vaccines, Now What? – Healthcare Economist
That’s the title of my newest publication with co-authors Marlon Graf, Rifat Tuly, Christoph Glaetzer, Stacey Hickson, and Joey Mattingly. The subtitle is “Methods to Guarantee Continued COVID-19 Vaccine Discovery and Expedite Entry“. The summary is beneath.
The coronavirus illness 2019 (COVID-19) pandemic has resulted in a catastrophic burden in each well being and financial prices. Regardless of the December 2020 emergency use authorizations of two COVID-19 vaccines, there’s nonetheless a lot work left to do. On this article, we assert that continued profitable COVID-19 vaccine insurance policies should have not less than two elements: (1) recognition of the worth that COVID-19 vaccines convey to society; and (2) collaboration throughout stakeholders to make sure fast inhabitants entry and uptake. Implementing these approaches will facilitate the containment of COVID-19 whereas making certain that innovators are capable of maintain the invention, growth, and supply of transformational medicines and vaccines, and—most significantly—enhance the lives of billions of people world wide.
Learn the entire article right here.